Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Tislelizumab × sintilimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Tislelizumab 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 IIIA Stage Non-small Cell Lung Cancer 1 Gastric Adenocarcinoma 1 Esophageal Neoplasms 1 Colorectal Cancer Metastatic 1 Advanced Solid Tumors 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04906044 2023-11-18

STARS-RC03

The First Hospital of Jilin University

Phase 1 Active not recruiting

Gastrointestinal

Tislelizumab

Data powered by HemOnc (CC BY 4.0) Colophon ⚡